Victory Capital Management Inc. Purchase 8,256 Shares of Hill-Rom Stake, Inc. (NYSE:HRC)

Victory Capital Management Inc. Purchase 8,256 Shares of Hill-Rom Stake, Inc. (NYSE:HRC)

Victory Capital Management Inc. grew its position in Hill-Rom Holdings, Inc. (NYSE:HRC) by 3.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 233,641 shares of the medical technology company’s stock after purchasing an additional 8,256 shares during the quarter. Victory Capital Management Inc. owned approximately 0.35% of Hill-Rom worth $22,056,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in HRC. Oakbrook Investments LLC increased its position in Hill-Rom by 34.5% during the third quarter. Oakbrook Investments LLC now owns 8,967 shares of the medical technology company’s stock worth $846,000 after acquiring an additional 2,300 shares during the period. Marshall Wace LLP acquired a new stake in Hill-Rom during the second quarter worth $10,392,000. Millennium Management LLC boosted its stake in Hill-Rom by 32.3% during the second quarter. Millennium Management LLC now owns 583,635 shares of the medical technology company’s stock worth $50,975,000 after buying an additional 142,654 shares in the last quarter. State of Alaska Department of Revenue boosted its stake in Hill-Rom by 14.5% during the third quarter. State of Alaska Department of Revenue now owns 7,674 shares of the medical technology company’s stock worth $724,000 after buying an additional 974 shares in the last quarter. Finally, Valeo Financial Advisors LLC boosted its stake in Hill-Rom by 18,894.9% during the third quarter. Valeo Financial Advisors LLC now owns 95,924 shares of the medical technology company’s stock worth $8,065,000 after buying an additional 95,419 shares in the last quarter. 82.59% of the stock is currently owned by institutional investors.

A number of equities research analysts have weighed in on the stock. Zacks Investment Research downgraded shares of Hill-Rom from a “buy” rating to a “hold” rating and set a $111.00 price target on the stock. in a research note on Wednesday. UBS Group assumed coverage on shares of Hill-Rom in a research note on Tuesday, November 27th. They set a “buy” rating and a $115.00 price target on the stock. ValuEngine upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating in a research note on Tuesday, November 6th. Raymond James lifted their price target on shares of Hill-Rom from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Monday, November 5th. Finally, Barclays assumed coverage on shares of Hill-Rom in a research note on Monday, October 15th. They set an “equal weight” rating and a $95.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $104.00.

Shares of NYSE:HRC traded down $0.29 on Thursday, hitting $95.75. The stock had a trading volume of 371,100 shares, compared to its average volume of 472,846. Hill-Rom Holdings, Inc. has a twelve month low of $78.16 and a twelve month high of $99.81. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.30 and a current ratio of 1.74. The company has a market capitalization of $6.46 billion, a PE ratio of 20.03, a P/E/G ratio of 1.34 and a beta of 0.94.

Hill-Rom (NYSE:HRC) last issued its earnings results on Friday, November 2nd. The medical technology company reported $1.63 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.12. Hill-Rom had a net margin of 8.86% and a return on equity of 21.10%. The company had revenue of $759.20 million for the quarter, compared to the consensus estimate of $750.90 million. During the same quarter in the previous year, the company earned $1.32 EPS. The firm’s revenue for the quarter was up 2.8% compared to the same quarter last year. On average, analysts forecast that Hill-Rom Holdings, Inc. will post 5.13 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, December 31st. Stockholders of record on Friday, December 14th will be paid a $0.20 dividend. The ex-dividend date of this dividend is Thursday, December 13th. This represents a $0.80 annualized dividend and a dividend yield of 0.84%. Hill-Rom’s dividend payout ratio is presently 16.84%.

In other news, SVP Andreas G. Frank sold 7,454 shares of the business’s stock in a transaction on Wednesday, November 28th. The shares were sold at an average price of $95.76, for a total value of $713,795.04. Following the sale, the senior vice president now owns 27,224 shares in the company, valued at approximately $2,606,970.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.90% of the stock is currently owned by insiders.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Read More: Rule of 72

Related posts

Leave a Comment